Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Concord Medical and MD Anderson Collaborate on Cancer Care for China

publication date: May 6, 2015
Concord Medical, which operates radiotherapy and diagnostic imaging centers in China hospitals, will collaborate with the MD Anderson Cancer Center at the University of Texas to develop a state-of-the-art cancer care program. Concord has begun operating oncology-focused hospitals, and it will implement the cancer program in its hospitals in Beijing, Shanghai and Guangzhou. The agreement is a first for MD Anderson in Asia. It will cover most provinces in China and in Singapore, and it will be an exclusive relationship for the Beijing and Shanghai hospitals. More details....

Stock Symbol: (NYSE: CCM)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital